Showing results (1301-1310 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|August 22, 2012
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancerKenneth J Pienta, Jean-Pascal Machiels, Dirk Schrijvers, et al.
Investigational New Drugs|August 1, 2012
Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancerBryan J Schneider, Julia Shin-Jung Lee, James A Hayman, et al.
Investigational New Drugs|August 7, 2012
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinomaAndrea Wang-Gillam, Stacey Plambeck-Suess, Peter Goedegebuure, et al.
Investigational New Drugs|August 25, 2012
Metabolism of patupilone in patients with advanced solid tumor malignanciesKevin R Kelly, Markus Zollinger, Frédéric Lozac'h, et al.
Investigational New Drugs|July 12, 2012
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapyYong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, et al.
Investigational New Drugs|August 18, 2012
Inhibition of topoisomerase II α activity and induction of apoptosis in mammalian cells by semi-synthetic andrographolide analoguesJintapat Nateewattana, Rungnapha Saeeng, Sakkasem Kasemsook, et al.
Investigational New Drugs|September 18, 1998
Phase I study of DMP 840 in pediatric patients with refractory solid tumorsJ Thompson, C B Pratt, C F Stewart, et al.
Investigational New Drugs|September 18, 1998
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusionG I Rodriguez, J G Kuhn, G Weiss, et al.
Investigational New Drugs|September 18, 1998
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinomaM M Zalupski, A F Shields, P A Philip, et al.
Investigational New Drugs|August 1, 1990
Phase I study of idarubicin administered orally on a daily x 3 scheduleD J Stewart, S Verma, J A Maroun, et al.
Pageof 372